Cancer treatments are the most expensive medical therapies in the United States, and a panel of experts said Friday it is time to rethink the cost of drugs that only add a few months to a patient's life.
Advertisement
Convening at the American Society of Clinical Oncology annual meeting in Atlanta this weekend, the six doctors on the panel noted that physicians and ethicists alike are struggling with the dilemma, according to Newsday. The cancer treatment industry is a $210 billion annual enterprise, the paper reported.
A steady stream of highly priced drugs has been pumped out by the pharmaceutical industry in recent years, and these medications tend to cost insurers and patients $2 000 (about R13 000) to $5 000 (about R33 000) a month, the panel said. However, these treatments have captured both headlines and the attention of patients desperate for a few more months of life.
"Everybody is affected," said Dr Neal Meropol, of the Fox Chase Cancer Centre in Philadelphia. ""The doctors, patients, insurers, entire economies." – (HealthDayNews)
Bookmark with:
What are social bookmarks?